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2004 TANDEM BMT MEETINGS
PREVIEW: LABORATORY RESEARCH,
PATIENT CARE, CLINICAL
INVESTIGATIONS, ALLIED PROGRAMS
The 2004 Tandem BMT Meetings
will be held Feb. 13–17 at Coronado
Springs Resort in Orlando. An outline
of the scientific program is provided
below.
As of the abstract deadline, the
number of submitted abstracts was
13% above the 2003 meetings and
77% ahead of the 2002 meetings.
Sixty-six of the submitted abstracts will
be selected for oral presentation, and
many others for posters.
Friday, Feb. 13
Hematopoietic Stem Cell Proliferation
and Expansion
• Genes that Control Stem Cell Prolif-
eration and Differentiation
Stephen G. Emerson
• Bmi is a Critical Regulator of Stem
Cell Self-Renewal
Guy Sauvageau
• Osteoblasts Regulate the Stem Cell
Niche: Definition and Manipulation
to Alter Transplant Outcomes
David T. Scadden
Hematopoietic Cell Transplantation for
Acute Lymphoblastic Leukemia
• Gene Expression Profiling in Acute
Lymphoblastic Leukemia
Bernard Fine
• A Comparison of Two Myeloabla-
tive Regimens for Allogeneic Hema-
topoietic Cell Transplantation for
Patients with Acute Lymphoblastic
Leukemia
David I. Marks
• Treatment Options for Adult Pa-
tients with Acute Lymphoblastic
Leukemia
Frederick R. Appelbaum
Biology and Genetics of Human Natural
Killer Cells
• Immunogenetics of the Killer Cell
Immunoglobulin Receptors
Peter Parham
• Natural Killer Cell Receptors In-
volved in the NK/Dendritic Cell In-
teractions
Alessandro Moretta
• The Ontogeny of NK Cell Receptors
and Implications for Hematopoietic
Cell Transplantation
Jeffrey S. Miller
Mesenchymal Stem Cells: Do They Have
a Role in Clinical Therapy?
Edwin M. Horwitz, Francesco Fras-
soni, Katarina LeBlanc, Frank Marini
Medical Decision Making: What Do We
Need to Know to Make Tough Choices?
Stephanie J. Lee, Corey Cutler
New Approaches to the Treatment of
Acute GvHD
Joseph H. Antin, Daniel Weisdorf,
Allen Chen, Daniel Couriel, Vincent
Ho, Richard Nash
Oral Abstracts (12 Presentations)
Medical Directors Conference
Welcome Reception
Saturday, Feb. 14
Immunogenetics of Hematopoietic Cell
Transplantation
• Genetics of the MHC
Mary Carrington
• HLA Matching in Unrelated HCT
Effie W. Petersdorf
• Clinical Significance of the Match-
ing of HLA Alleles, NK Cell Recep-
tors and Minor HAs in Hematopoi-
etic Stem Cell Transplantation from
Unrelated Donors
Yasuo Morishima
Recent Advances in Treatment of Adult
and Pediatric AML
• Genetic Basis of AML: Therapeutic
Implications
Gary Gilliland
• Current Therapeutic Strategies in
Adult AML
Martin Tallman
• Advances in Treatment of Pediatric
AML
Robert J. Arceci
Tolerance Induction/Regulatory T-Cells
• Advances in Lymphocyte Costimu-
latory Receptors
Carl H. June
• Use of Regulatory T-Cells to Prevent
GvHD
Bruce R. Blazar
• Costimulatory Blockade to Prevent
GvHD
Lee M. Nadler
Oral Abstracts (24 Presentations)
Poster Session I
Sunday, Feb. 15
The Role of BMT for CML in the
Gleevec Era
• Imatinib and the Current Standard
of Care for CML
Jorge Cortes
• Ablative Allogeneic Transplantation
for CML
Jerald Radich
• Nonmyeloablative Allogeneic Trans-
plantation, Immunotherapy and
Multimodality Treatment for CML
Richard E. Champlin
Clinical Resource Challenges: 2004
• Management of the “Cured” Patient
John R. Wingard
• Stem Cell Transplant Center Charac-
teristics and Posttransplant Mortality
Fausto Loberiza, Jr.
• What is Quality in a Transplant Pro-
gram?
C. Fred LeMaistre
792
Minor Histocompatibility Antigens— Biol-
ogy and Clinical Relevance
• Molecular Basis of Minor Histocom-
patibility Antigens and their Role in
GvHD and GvL Responses
Stanley Riddell
• Targeting Immunodominant Minor
Histocompatibility Antigens
Claude Perreault
• Identification of Two Novel Minor
Histocompatibility Antigens by Link-
age Analysis and Their Clinical Rel-
evance
Yoshiki Akatsuka
E. Donnall Thomas Lecture: Past,
Present, and Future of Hematopoietic
Transplantation
Richard E. Champlin
Animal Models for GvHD/GvL: How
Relevant Are They for Clinical HSCT?
Marcel R. M. van den Brink, Robert
Korngold
Statistical Issues in Bone Marrow Trans-
plantation Trials—Techniques for Com-
peting
John Klein, Ruta Bajorunaite, Mei-Jie
Zhang
Chemokines—Mechanisms of Mobiliza-
tion
Robert Negrin, Edmund Waller
Current Strategies in Unrelated Donor
Selection
Daniel Weisdorf, Stella M. Davies,
Claudio Anasetti, Carolyn Hurley
ASBMT President’s Dinner
Monday, Feb. 16
New Treatment Strategies in Multiple
Myeloma
• Autologous Transplantation
Jean Luc Harrousseau
• Allogeneic Transplantation
William Bensinger
• Novel Biologically Based Therapies
Kenneth Anderson
Lineage Commitment in the Immune
System
• Notch Signaling Directs Multiple
Cell Rate Decisions During Hema-
topoiesis
Warren S. Pear
• How T-Lymphocytes Differentiate
During Immunity
Steven L. Reiner
• Tec Kinases in T-Cell Differentiation
Leslie J. Berg
Gene Therapy of Hematopoietic Stem Cells
• Surprising Findings in the Clonal
Activity of Gene-Corrected Hema-
topoietic Stem Cells
Christof von Kalle
• Gene Therapy for X-SCID—the UK
Experience
Adrian Thrasher
• Ex-Vivo Selection in the Large Ani-
mal Model
Hans-Peter Kiem
Best Abstracts
Oral Abstracts (12 Presentations)
Poster Session II
Tuesday, Feb. 17
HSC Plasticity: Separating Promise from
Hype
• Who Came First: Blood or Blood
Vessels
Edward Scott
• Stem Cells Have a Heart
Donald Orlic
• Adult Stem Cell Plasticity
Diane Krause
Cellular Therapy for Infectious Disease
• Cellular Therapy for CMV Infection
Hermann Einsele
• Cellular Therapy for EBV Infection
Richard O’Reilly
• The Role of Cytotoxic T-Cells in Con-
trol of CMV Infection
Stanley Riddell
International Session
Jane Apperley, Alexandra H. Filipovich
• Umbilical Cord Blood Transplants in
Adults: USA Experience
Mary J. Laughlin
• Umbilical Cord Blood Transplants in
Adults: European Experience
Eliane Gluckman
• Cord Blood Banking: Potentials and
Difficulties
E. J. Shpall
• Unrelated Transplants: Is There a
Need for Cord Blood?
Andrea Bacigalupo
Oral Abstracts (6 Presentations)
Late Effects: Are We Doing Enough for
Our Survivors?
J. Douglas Rizzo, Ge´rald Socie´
Tumor Vaccines After BMT
Jeffrey Molldrem, Hyam I. Levitsky
Oral Abstracts (6 Presentations)
RESERVE HOUSING BY JAN. 12 FOR
TANDEM BMT MEETINGS
The deadline is Jan. 12 for housing
for the 2004 Tandem BMT Meetings
in Orlando. After that date, sleeping
accommodations at special conven-
tion rates are on a “space available”
basis. A Housing Reservation Form
can be downloaded from the ASBMT
Web site, www.asbmt.org, or you
may call Coronado Springs Resort res-
ervations at (407) 939-1020 and
mention the Tandem BMT Meetings
to obtain special conference rates of
$138 for a single or double room.
Meeting registration also is available
online at the ASBMT Web site.
SIX RELATED CONFERENCES AT
CORONADO SPRINGS RESORT
In addition to the main scientific
program, a number of allied health
professional groups will be holding
conferences immediately before and
during the Tandem BMT Meetings:
• FACT Training Courses for Inspec-
tion and Inspectors (Feb. 12)
• BMT Pharmacists Conference (Feb.
12-13)
• Clinical Research Associates Data Man-
agement Workshops (Feb. 12-14)
• BMT Medical Directors Conference
(Feb. 13)
• BMT Center Administrators Confer-
ence (Feb. 14-15)
• Oncology Nursing Conference (Feb.
15-17)
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